March was the peak in terms of sales for the pharmaceutical market, but the following months came with decline on all channels, according to the same source.
“The result was a sharp decrease in the number of consumers in open circuit pharmacies, but also in the number of hospitalizations (being registered only in hospitals with Covid regime),” the report of Antibiotice, the largest Romanian-held pharmaceutical manufacturer, reads.
The lack of patients hurt chain pharmacies especially, whose revenue was 14% lower in the first half compared with the year-ago period, according to Cegedim. National pharmacy chains saw sales of only RON3 billion in the first half, while independent pharmacies saw sales of more than RON4.4 billion.
(English version by Loredana Fratila-Cristescu)